Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...
In our years advising, founding, leading, and benefitting from nonprofit organizations, we have often seen them respond to these and other challenges by doubling down on rigorous, well-established ...
Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 10:00 AM ESTCompany ParticipantsNadim Ahmed - ...
Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.
A division of the U.S. Agency for International Development eliminated by Trump administration cuts last year was reborn ...
Over time, places like Monte Carlo and Las Vegas turned gambling into a global industry, packed with bright lights, high stakes, and non-stop traffic. Casinos like the Bellagio, MGM Grand, and Marina ...
This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...
TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Company collaborating with third parties using "proprietary artificial intelligence and machine learning technologies to identify nonspecific responses and understand and predict susceptibility to ...
Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 12:15 PM ESTCompany ParticipantsZachary Roberts ...
The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results